UPDATE: Stifel Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Buy

September 9, 2021 3:10 AM EDT Send to a Friend
(Updated - September 9, 2021 4:53 AM EDT)

Stifel analyst Paul Matteis upgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login